Similar articles

• Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.

  Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Hotta K, et al. J Clin Oncol. 2004 Oct 1;22(19):3852-9. doi: 10.1200/JCO.2004.02.109. Epub 2004 Aug 23. J Clin Oncol. 2004. PMID: 15326195
• Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.

  D'Addario G, Pintilie M, Leighl NB, Feld R, Cerny T, Shepherd FA. D'Addario G, et al. J Clin Oncol. 2005 May 1;23(13):2926-36. doi: 10.1200/JCO.2005.03.045. Epub 2005 Feb 22. J Clin Oncol. 2005. PMID: 15728229
• A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.

  Jiang J, Liang X, Zhou X, Huang R, Chu Z. Jiang J, et al. Lung Cancer. 2007 Sep;57(3):348-58. doi: 10.1016/j.lungcan.2007.03.014. Epub 2007 May 7. Lung Cancer. 2007. PMID: 17485133
• Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.

  Vilmar A, Sørensen JB. Vilmar A, et al. Lung Cancer. 2009 May;64(2):131-9. doi: 10.1016/j.lungcan.2008.08.006. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804893 Review.
• Oxaliplatin doublets in non-small cell lung cancer: a literature review.

  Cortinovis D, Bidoli P, Zilembo N, Fusi A, Bajetta E. Cortinovis D, et al. Lung Cancer. 2008 Jun;60(3):325-31. doi: 10.1016/j.lungcan.2008.03.005. Epub 2008 Apr 25. Lung Cancer. 2008. PMID: 18440088 Review.